Wealth Enhancement Advisory Services LLC Decreases Stock Position in Waters Corporation $WAT

Wealth Enhancement Advisory Services LLC cut its position in Waters Corporation (NYSE:WAT) by 2.2% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 11,365 shares of the medical instruments supplier’s stock after selling 254 shares during the quarter. Wealth Enhancement Advisory Services LLC’s holdings in Waters were worth $3,980,000 at the end of the most recent reporting period.

Several other large investors also recently added to or reduced their stakes in the company. Mn Services Vermogensbeheer B.V. raised its stake in Waters by 7.0% in the 2nd quarter. Mn Services Vermogensbeheer B.V. now owns 22,933 shares of the medical instruments supplier’s stock valued at $8,005,000 after acquiring an additional 1,500 shares during the period. Swedbank AB lifted its stake in shares of Waters by 25.8% during the 2nd quarter. Swedbank AB now owns 40,526 shares of the medical instruments supplier’s stock valued at $14,145,000 after buying an additional 8,305 shares in the last quarter. Sumitomo Mitsui DS Asset Management Company Ltd boosted its holdings in Waters by 2.8% in the 2nd quarter. Sumitomo Mitsui DS Asset Management Company Ltd now owns 6,728 shares of the medical instruments supplier’s stock worth $2,348,000 after buying an additional 185 shares during the period. Sivia Capital Partners LLC purchased a new position in Waters in the 2nd quarter valued at approximately $232,000. Finally, Gateway Investment Advisers LLC grew its stake in Waters by 3.0% in the 2nd quarter. Gateway Investment Advisers LLC now owns 2,085 shares of the medical instruments supplier’s stock valued at $728,000 after buying an additional 60 shares in the last quarter. Hedge funds and other institutional investors own 94.01% of the company’s stock.

Waters Trading Down 1.5%

Shares of WAT opened at $288.25 on Friday. The company has a debt-to-equity ratio of 0.55, a current ratio of 1.75 and a quick ratio of 1.22. Waters Corporation has a 1-year low of $275.05 and a 1-year high of $423.56. The company has a market capitalization of $17.16 billion, a P/E ratio of 25.99, a P/E/G ratio of 2.73 and a beta of 1.07. The firm’s 50 day simple moving average is $294.98 and its 200 day simple moving average is $328.37.

Waters (NYSE:WAT) last posted its quarterly earnings data on Monday, August 4th. The medical instruments supplier reported $2.95 earnings per share for the quarter, beating the consensus estimate of $2.93 by $0.02. Waters had a net margin of 21.71% and a return on equity of 38.60%. The firm had revenue of $771.33 million for the quarter, compared to analysts’ expectations of $745.96 million. During the same quarter last year, the company posted $2.63 EPS. The business’s quarterly revenue was up 8.8% on a year-over-year basis. Waters has set its Q3 2025 guidance at 3.150-3.250 EPS. FY 2025 guidance at 12.950-13.050 EPS. Sell-side analysts forecast that Waters Corporation will post 12.86 earnings per share for the current fiscal year.

Analysts Set New Price Targets

WAT has been the subject of a number of analyst reports. Jefferies Financial Group set a $385.00 price target on Waters and gave the stock a “buy” rating in a report on Monday, August 4th. Wells Fargo & Company dropped their price objective on Waters from $330.00 to $315.00 and set an “equal weight” rating on the stock in a report on Tuesday, August 5th. Scotiabank reaffirmed a “sector outperform” rating and set a $465.00 target price on shares of Waters in a report on Friday, July 11th. Bank of America increased their price target on shares of Waters from $370.00 to $375.00 and gave the stock a “neutral” rating in a report on Thursday, June 26th. Finally, Deutsche Bank Aktiengesellschaft set a $315.00 price objective on shares of Waters and gave the company a “hold” rating in a research note on Tuesday, August 5th. One investment analyst has rated the stock with a Strong Buy rating, five have given a Buy rating and nine have given a Hold rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus target price of $378.73.

Waters Company Profile

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.